Evaluation of protection by COVID-19 vaccines after deployment in low and lower-middle income countries

The availability and use of vaccines for the coronavirus disease 2019 (COVID-19) in low and middle-income countries (L/MICs) lags far behind more affluent countries, and vaccines currently used in L/MICs are predominantly of lower efficacy. As vaccines continue to be rolled out in L/MICs, successful...

Descripción completa

Detalles Bibliográficos
Autores principales: Clemens, John, Aziz, Asma Binte, Tadesse, Birkneh Tilahun, Kang, Sophie, Marks, Florian, Kim, Jerome
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703050/
https://www.ncbi.nlm.nih.gov/pubmed/34977517
http://dx.doi.org/10.1016/j.eclinm.2021.101253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703050/
https://www.ncbi.nlm.nih.gov/pubmed/34977517
http://dx.doi.org/10.1016/j.eclinm.2021.101253

Ejemplares similares